Menopausal hot flashes and insulin resistance

Menopause

Volumn 19, Issue 10, 2012, Pages 1116-1120

  Tuomikoski, Pauliina ^a   Ylikorkala, Olavi ^a   Mikkola, Tomi S ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Glucose; Homeostasis model assessment; Insulin; Menopause; Vasomotor symptoms

Indexed keywords

C REACTIVE PROTEIN; ESTRADIOL; GLUCOSE; INSULIN; SEX HORMONE BINDING GLOBULIN;

ADULT; AMENORRHEA; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CALCULATION; DISEASE ASSOCIATION; DISEASE SEVERITY; ESTRADIOL BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HOT FLUSH; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; POSTMENOPAUSE; PROSPECTIVE STUDY; SAMPLE SIZE; SYMPTOM;

BODY MASS INDEX; C-REACTIVE PROTEIN; ESTRADIOL; FEMALE; HOT FLASHES; HUMANS; INSULIN; INSULIN RESISTANCE; MENOPAUSE; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; SEX HORMONE-BINDING GLOBULIN;

EID: 84867019049     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e3182503d5d     Document Type: Article

References (36)

1. Dubey RK, Imthurn B, Barton M, Jackson EK. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc Res 2005;66:295-306.
2. Mikkola TS, Clarkson TB. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res 2002;53:605-619.
3. Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, Hess R, Matthews KA. Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study. Circulation 2008; 118:1234-1240.
4. Gast GC, Grobbee DE, Pop VJ, et al. Menopausal complaints are associated with cardiovascular risk factors. Hypertension 2008;51:1492-1498.
5. Tuomikoski P, Ebert P, Groop PH, et al. Evidence for a role of hot flushes in vascular function in recently postmenopausal women. Obstet Gynecol 2009;113:902-908.
6. Tuomikoski P, Haapalahti P, Ylikorkala O, Mikkola TS. Vasomotor hot flushes and 24-hour ambulatory blood pressure in recently post-menopausal women. Ann Med 2010;42:216-222.
7. Gast GC, Samsioe GN, Grobbee DE, Nilsson PM, van der Schouw YT. Vasomotor symptoms, estradiol levels and cardiovascular risk profile in women. Maturitas 2010;66:285-290.
8. Mikkola TS. The hot flushVa determinant for vascular effects of estrogen? Maturitas 2011;69:287-288.
9. Szmuilowicz ED, Manson JE, Rossouw JE, et al. Vasomotor symptoms and cardiovascular events in postmenopausal women. Menopause 2011; 18:603-610.
10. Freedman RR. Pathophysiology and treatment of menopausal hot flashes. Semin Reprod Med 2005;23:117-125.
11. Hoikkala H, Haapalahti P, Viitasalo M, et al. Association between vas-omotor hot flashes and heart rate variability in recently postmenopausal women. Menopause 2010;17:315-320.
12. Thurston RC, Christie IC, Matthews KA. Hot flashes and cardiac vagal control: a link to cardiovascular risk? Menopause 2010;17:456-461.
13. Hautamäki H, Piirilä P, Haapalahti P, et al. Cardiovascular autonomic responsiveness in postmenopausal women with and without hot flushes. Maturitas 2011;68:368-373.
14. Grassi G. Sympathetic overdrive and cardiovascular risk in the metabolic syndrome. Hypertens Res 2006;29:839-847.
15. Lambert GW, Straznicky NE, Lambert EA, Dixon JB, Schlaich MP. Sympathetic nervous activation in obesity and the metabolic syndromeV causes, consequences and therapeutic implications. Pharmacol Ther 2010; 126:159-172.
16. Reaven GM. Relationships among insulin resistance, type 2 diabetes, essential hypertension, and cardiovascular disease: similarities and differences. J Clin Hypertens 2011;13:238-243.
17. Cagnacci A, Cannoletta M, Caretto S, Zanin R, Xholli A, Volpe A. Increased cortisol level: a possible link between climacteric symptoms and cardiovascular risk factors. Menopause 2011;18:273-278.
18. Sowers M, Derby C, Jannausch ML, Torrens JI, Pasternak R. Insulin resistance, hemostatic factors, and hormone interactions in pre-and perimenopausal women: SWAN. J Clin Endocrinol Metab 2003;88: 4904-4910.
19. Ndumele CE, Pradhan AD, Ridker PM. Interrelationships between inflammation, C-reactive protein, and insulin resistance. J Cardiometab 2006; 1:190-196.
20. Tuomikoski P, Mikkola TS, Hämäläinen E, Tikkanen MJ, Turpeinen U, Ylikorkala O. Biochemical markers for cardiovascular disease in recently postmenopausal women with and without hot flashes. Menopause 2009; 17:145-151.
21. Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H. Methodologic lessons learned from hot flash studies. J Clin Oncol 2001;19:4280-4290.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and A-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
23. Tuomikoski P, Ebert P, Groop PH, et al. Effect of hot flushes on vascular function: a randomized controlled trial. Obstet Gynecol 2009;114: 777-785.
24. Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175-191.
25. The World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Report of a WHO/IDF Consultation. Geneva, Switzerland: WHO Press, World Health Organization, 2006.
26. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008;294: E15-E26.
27. Stearns V, Ullmer L, López JF, et al. Hot flushes. Lancet 2002;360: 1851-1861.
28. Whitcroft S, Herriot A. Insulin resistance and management of the menopause: a clinical hypothesis in practice. Menopause Int 2011;17:24-28.
29. Szmuilowicz ED, Stuenkel CA, Seely EW. Influence of menopause on diabetes and diabetes risk. Nat Rev Endocrinol 2009;5:553-558.
30. Tuomikoski P, Ylikorkala O, Mikkola TS. Menopausal hot flushes and vascular health. Ann Med 2011;43:283-291.
31. Szmuilowicz ED, Manson JE. Menopausal vasomotor symptoms and cardiovascular disease. Menopause 2011;18:345-347.
32. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabetic Med 2002;19:527-534.
33. Vitale C, Mendelsohn ME, Rosano GM. Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol 2009;6: 532-542.
34. Bechlioulis A, Kalantaridou SN, Naka KK, et al. Endothelial function, but not carotid intima-media thickness, is affected early in menopause and is associated with severity of hot flushes. J Clin Endocrinol Metab 2010;95:1199-1206.
35. Gold EB, Colvin A, Avis N, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: Study of Women's Health Across the Nation. Am J Public Health 2006;96:1226-1235.
36. Thurston RC, Santoro N, Matthews KA. Adiposity and hot flashes in midlife women: a modifying role of age. J Clin Endocrinol Metab 2011; 96:E1588-E1595.